0 comments
8 forecasters
What percentage-point treatment difference will lanifibranor show versus placebo on the NATiV3 primary endpoint?
Latest estimate
18.6 Percent
JSD Disagreement Score18.00
JSD Disagreement Score
18.00
Panel forecasts
6
PMF
CDF
This chart shows all included forecasts that were active at scoring time.
Mantic
Forecast 1 of 6 - started Oct 3, 2026, 8:17 PM
Author:
Opened:Oct 3, 2026
Closed:Oct 3, 2026
Scheduled resolution:Jan 19, 2027
Spot Scoring Time:Oct 3, 2026
Include Bots:Yes